GDF15 and Crohn disease: Further analysis using ANOVA to separately compare the Crohn’s disease group, the ulcerative colitis group, and the control group revealed consistently elevated plasma GDF-15 levels in both CD and UC (Kruskal–Wallis test, p < 0.001), as illustrated in Figure 2.